Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

FDA clears first over-the-counter wearable device for continuous glucose monitoring
The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone.
Are GLP-1 agonists safe? FDA finds no evidence popular weight loss medications cause suicidal thoughts or actions
The popular drugs, originally developed to treat diabetes, are being used more and more in the United States to help obese and overweight patients lose weight.
‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity
While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.
Roche spends $2.7B to acquire biotech company with multiple obesity, diabetes drugs in development
Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.
CVD deaths have increased dramatically, undoing years of progress
The COVID-19 pandemic undid years and years of progress in terms of preventing CVD-related deaths. What can be done to help reverse this trend once and for all?

The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin.

June 29, 2023

Novo Nordisk close to acquiring French medical device company for $165M

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

June 5, 2023

Medtronic acquires insulin patch manufacturer for $738M

The deal represents a significant step forward for Medtronic's diabetes portfolio.

May 25, 2023

AI helps ID patients who would benefit most from strict blood pressure control

The study's findings suggest that AI can help clinicians provide more personalized care than ever before.

April 18, 2023

FDA announces recall of 4.2M Abbott devices after hundreds of incidents, including multiple fires

Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.

April 7, 2023

Incoming 2023-2024 American College of Cardiology (ACC) president Hadley Wilson, MD, shares insights on how to create health equity through both ACC programs and hospital grassroots community outreach programs. He outlines four programs his heart hospital is piloting in its community in Charlotte, North Carolina.

How cardiologists can address health disparities in their communities

Incoming 2023-2024 American College of Cardiology president Hadley Wilson, MD, shared insights on how to create health equity through grassroots community outreach programs.

February 28, 2023

Christine Seidman, MD, director of the cardiovascular genetics program, cardiovascular medicine specialist, Brigham & Women’s Hospital, discusses the use of genetics to crack the code of cardiovascular diseases to enable earlier prevention and interventions. She was named the winner of the American Heart Association (AHA) 2022 Research Achievement Award, AHA's highest honor.

VIDEO: Using genetics in cardiology to enable earlier interventions

Christine Seidman, MD, director of the cardiovascular genetics program at Brigham & Women’s Hospital, spoke to us about using genetics to crack the code of cardiovascular disease.

January 6, 2023

Cardiovascular disease still the No. 1 cause of death in the world

A new global report, based on data from 204 different countries and territories, has been published in full in the Journal of the American College of Cardiology.

December 13, 2022

Around the web

Cardiovascular Business

FDA announces new recall of delivery catheters after patient’s death

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

Cardiovascular Business

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.

Cardiovascular Business

The push for an independent cardiology board continues

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Heart Health

FDA clears first over-the-counter wearable device for continuous glucose monitoring

Are GLP-1 agonists safe? FDA finds no evidence popular weight loss medications cause suicidal thoughts or actions

‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity

Roche spends $2.7B to acquire biotech company with multiple obesity, diabetes drugs in development

CVD deaths have increased dramatically, undoing years of progress

Around the web